MBRX ▼ -0.2% - Moleculin Biotech, Inc.
$MBRX - Moleculin Completes Dosing Patients in Part A of Pivotal MIRACLE Trial; Comprehensive Data Readout on Track for Q1 2027
30-OCT-2026 08:40 AM ET
Share this post
More filings for $MBRX
MBRX ▼ -95.0% - Moleculin Biotech, Inc.Oct 20, 2026MBRX ▼ -10.8% - Moleculin Biotech, Inc.Oct 16, 2026MBRX ▼ -1.8% - Moleculin Biotech, Inc.Sep 29, 2026MBRX ▼ -1.7% - Moleculin Biotech, Inc.Sep 28, 2026MBRX ▲ +14.5% - Moleculin Biotech, Inc.Sep 25, 2026MBRX ▲ +4.2% - Moleculin Biotech, Inc.Sep 14, 2026
View full $MBRX filing history →💬 Comments
Loading comments…
Leave a comment